FDA Drug Application (020338) for DIFFERIN by GALDERMA LABS LP

Back to FDA Applications sponsored by GALDERMA LABS LP

Application Number020338
Product Number001
FormSOLUTION;TOPICAL
Dosage0.1% **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameDIFFERIN
Active IngredientADAPALENE

Active IngredientCount
List of drugs with Active Ingredient ADAPALENE6


Back to FDA Applications sponsored by GALDERMA LABS LP